DARATUMUMAB, LENALIDOMIDE AND DEXAMETASONE (DRD) IN PLASMATIC CELL LEUKEMIA (LCP): THREE PATIENTS, THREE RESULTS - Lopez Pereira, P.; Del Campo Rincon, J. F.; Munoz Linares, C.; Vicuna Andres, I; Alegre Amor, A.; Aguado Bueno, B.; (Haematologica, 2019)